Navigation Links
Micromet Reports Fourth Quarter and Full Year 2009 Financial Results
Date:3/4/2010

  • Reported interim results from a Phase 1 trial of blinatumomab in patients with B-cell non-Hodgkin's lymphoma (NHL) - At the December 2009 ASH Annual Meeting, the Company announced the presentation of interim data from its ongoing Phase 1 trial of blinatumomab in patients with relapsed/refractory NHL. At the therapeutic dose level (60 micrograms), 100 percent of evaluable patients (12 of 12) had an objective partial or complete response after their first four to eight weeks of treatment.

  • Announced plans to expand clinical development of blinatumomab in leukemia -  At its R&D Day in February, the Company announced its intent to initiate three blinatumomab trials in 2010, including a European pivotal trial in MRD-positive adult ALL, a Phase 2 trial in relapsed/refractory adult ALL and a Phase 2 trial in relapsed/refractory adult chronic lymphocytic leukemia.  In addition, the Company expects to discuss its regulatory strategy for blinatumomab in pediatric ALL with the FDA and EMEA during the course of 2010.  The Company has been working with the leading study groups for the treatment of ALL to plan and conduct the respective studies.


'/>"/>
SOURCE Micromet, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine news :

1. Data from Phase 1 Study Confirm High Response Rate of Micromets Blinatumomab in Patients with Non-Hodgkins Lymphoma
2. Micromet, Inc. Reports Second Quarter 2009 Financial Results
3. Phase 1 Study Initiated with Micromet Anti-GM-CS Human Antibody MT203
4. Micromet, Inc. Reports First Quarter 2009 Financial Results
5. Micromet To Present at the ROTH 21st Annual Orange County Growth Stock Conference
6. Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Presented at American Society of Hematology Annual Meeting
7. Micromet to Present at the Piper Jaffray 20th Annual Health Care Conference
8. Micromet, Inc. Reports Second Quarter 2008 Financial Results
9. Micromet, Inc. Reports First Quarter 2008 Financial Results
10. Micromet and MedImmune to Present New Clinical Data for Anti-CD19 BiTE(R) Antibody at American Society of Hematology Annual Meeting Showing Objective Clinical Responses in Relapsed Non-Hodgkins Lymphoma Patients
11. Micromets BiTE(R) Antibodies Reveal Unique Mode of Action
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... Fla. (PRWEB) September 30, 2014 Lea ... is giving breast cancer patients a new, more practical ... , Women who undergo mastectomies, biopsies and lumpectomy surgeries ... promote healing. But after seeing her patients describe the ... compelled to create a new bra in her spare ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 AxoGen, ... focused on the peripheral nerve repair market, announced the ... during the American Society for Surgery of the Hand ... in Boston. , The ASSH Best ... Utilization of Processed Nerve Allografts for Large Gap Nerve ...
(Date:9/30/2014)... Brig Hart, one of the most ... 500 Diamond-ranked professionals using his systematic way of building ... The Life Support System for Ultimate Success , founded ... using his experiences and successes over the past 30 ... and methodology taught by Brig in this system, Mick ...
(Date:9/30/2014)... 30, 2014 During this online ... approaches to health including achieving hormonal balance, relieving ... and detoxification. , The details ... Date: October 6-9, 2014, Location: Online Event, Registration: ... http://www2.hotzehwc.com/naturalhealthsummitregistration , Monday, October 6th, Steven F. ...
(Date:9/30/2014)... 2014 Timber Home Living Magazine is documenting ... Olsen family’s reclaimed Douglas fir timber frame home in Austerlitz, ... from architectural planning, to the frame raising, to enclosure, to ... Energy Works, after following the timber framing company for years ... dream vacation home on land they fell in love with ...
Breaking Medicine News(10 mins):Health News:Surgeon Creates New Bra for Breast Cancer Patients, Post-Surgery 2Health News:Surgeon Creates New Bra for Breast Cancer Patients, Post-Surgery 3Health News:AxoGen, Inc. Announces Presentation of Clinical Data for Avance® Nerve Graft at American Society for Surgery of the Hand 2014 Annual Meeting 2Health News:AxoGen, Inc. Announces Presentation of Clinical Data for Avance® Nerve Graft at American Society for Surgery of the Hand 2014 Annual Meeting 3Health News:AxoGen, Inc. Announces Presentation of Clinical Data for Avance® Nerve Graft at American Society for Surgery of the Hand 2014 Annual Meeting 4Health News:AxoGen, Inc. Announces Presentation of Clinical Data for Avance® Nerve Graft at American Society for Surgery of the Hand 2014 Annual Meeting 5Health News:Brig Hart Announces the First Diamond Elite Representatives using his Life Support System 2Health News:Brig Hart Announces the First Diamond Elite Representatives using his Life Support System 3Health News:Hotze Health & Wellness Center Announces First Natural Health Summit 2Health News:Reclaimed Timber Frame Home By New Energy Works Featured in Timber Home Living Magazine 2Health News:Reclaimed Timber Frame Home By New Energy Works Featured in Timber Home Living Magazine 3
... one of the most lethal cancers, with fewer than five ... new study that peers deeply into the genetics of pancreatic ... early diagnosis. In contrast to earlier predictions, many pancreatic tumors ... become lethal after the first genetic perturbations appear. "There ...
... People who regularly eat whole grains rather than refined grains ... a higher risk for heart disease and type 2 diabetes, ... (VAT) -- the fat that surrounds the intra-abdominal organs -- ... cholesterol and insulin resistance, health risk factors collectively known as ...
... , TUESDAY, Oct. 26 (HealthDay News) -- As many ... if people followed five simple healthy lifestyle recommendations, Danish ... overall health as well -- include exercise, a good ... weight, the researchers say. "Even a modest difference ...
... University and University of North Carolina (UNC) researchers report ... Research that narcotics and diagnostic testing are overused ... may overlook more effective treatments for neck pain, such ... study, evidence to support the effectiveness of therapeutic exercise ...
... Steven Reinberg HealthDay Reporter , TUESDAY, Oct. 26 ... the blood-thinning drug Plavix (clopidogrel) may be at increased risk ... finds. Having the gene variants seems to reduce the ... developing blood clots in the stent, suffering a heart attack ...
... -- Children who survive cancer face an increased risk ... The findings highlight the increased need for long-term ... researchers said. "Current treatments have dramatically increased survival ... many cancer therapies -- including surgery, radiation, and chemotherapy ...
Cached Medicine News:Health News:Revising the timeline for deadly pancreatic cancer 2Health News:Revising the timeline for deadly pancreatic cancer 3Health News:Eating Whole Grains, Fewer Refined Grains, May Help Heart 2Health News: Healthy Living Can Prevent Nearly 25% of Colorectal Cancers 2Health News: Healthy Living Can Prevent Nearly 25% of Colorectal Cancers 3Health News:Narcotics and diagnostics overused in treatment of chronic neck pain 2Health News:Gene Mutations May Blunt Plavix's Effectiveness, Study Finds 2Health News:Gene Mutations May Blunt Plavix's Effectiveness, Study Finds 3Health News:Childhood Cancer Survivors Risk Future GI Problems 2
(Date:9/30/2014)... DIEGO , Sept. 30, 2014 ... three-dimensional biology company focused on delivering breakthrough 3D ... Liver Model has been selected as a finalist in ... 2014 Most Innovative New Product Awards, sponsored by ... of innovative technology and life sciences products in ...
(Date:9/30/2014)... -- The Corporate Whistleblower Center is urging ER doctors, ... if they have well documented proof of a ... sent home, as an intentional way to overbill ... the Center would like to explain. http://CorporateWhistleblowerCenter.Com ... Photo - http://photos.prnewswire.com/prnh/20140929/149017 ...
(Date:9/30/2014)... EXECUTIVE SUMMARY The present report ... - Increasing Demand from Ageing Population to Drive ... past, present and future outlook. The report discusses ... market with outlook to 2017. Statistics include functional ... sub-segments of the industry, ongoing trends and developments, ...
Breaking Medicine Technology:Organovo Inc. Selected As A Finalist In 27th Annual CONNECT Most Innovative New Product Awards 2Organovo Inc. Selected As A Finalist In 27th Annual CONNECT Most Innovative New Product Awards 3Corporate Whistleblower Center Urges ER Doctors or Nurse Managers to Call Them if They Have Proof of a Hospital Needlessly Admitting Medicare Patients Instead of Sending Them Home 2Corporate Whistleblower Center Urges ER Doctors or Nurse Managers to Call Them if They Have Proof of a Hospital Needlessly Admitting Medicare Patients Instead of Sending Them Home 3Corporate Whistleblower Center Urges ER Doctors or Nurse Managers to Call Them if They Have Proof of a Hospital Needlessly Admitting Medicare Patients Instead of Sending Them Home 4North America Nutraceuticals Industry Outlook to 2017- Increasing Demand from Ageing Population to Drive Growth 2North America Nutraceuticals Industry Outlook to 2017- Increasing Demand from Ageing Population to Drive Growth 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: